MedPath

ASCENEURON PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of Oral ASN51 in Healthy Subjects and Subjects With Alzheimer's Disease

Phase 1
Terminated
Conditions
Alzheimer Disease
Interventions
Drug: Placebo
First Posted Date
2021-02-18
Last Posted Date
2023-01-17
Lead Sponsor
Asceneuron Pty Ltd.
Target Recruit Count
25
Registration Number
NCT04759365
Locations
🇦🇺

Nucleus Network, Melbourne, Victoria, Australia

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.